ALPEK (ALPEKA) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
16 Nov, 2025Executive summary
Solid performance in plastics and chemicals offset polyester margin pressure from global oversupply, trade disruptions, and operational outages.
Strategic focus on productivity, competitiveness, innovation, and financial flexibility, including facility closures and asset divestitures.
Progressing toward integrated hubs, with $20 million in expected annual savings by 2026 and production reallocation for efficiency.
Cedar Creek PET facility shutdown announced to optimize footprint and enhance operational efficiency.
Debt refinancing extended average maturity to 4.7 years, reinforcing liquidity and financial flexibility.
Financial highlights
Volume was 1.1–1.12 million tons, down 7% year-over-year and flat sequentially.
Comparable EBITDA was $125 million, down 21% year-over-year and flat sequentially; reported EBITDA was $102 million.
Operating Free Cash Flow reached $48 million, up $40 million from the previous quarter.
Net debt stood at $1.9 billion, with a Net Debt/EBITDA ratio of 3.5x.
Revenues were $1.68 billion, down 2% sequentially and 13% year-over-year.
Outlook and guidance
Comparable EBITDA guidance revised to $525–$575 million for 2025, reflecting ongoing margin volatility and macro uncertainty.
CapEx guidance updated to $130–$150 million, with $100 million for maintenance.
No dividend expected for 2025; focus remains on financial flexibility and deleveraging.
Free Cash Flow for 2025 expected around $200 million.
Ongoing industry headwinds expected, including margin pressure and U.S. tariff uncertainty.
Latest events from ALPEK
- 2026 guidance targets $450–$500M EBITDA, with deleveraging and cost controls prioritized.ALPEKA
Q4 202511 Feb 2026 - Stable volumes, $75M cost savings, and lower leverage support 2024 guidance.ALPEKA
Q2 20242 Feb 2026 - Q3 delivered record EBITDA, raised guidance, and progress on spin-off and cost savings.ALPEKA
Q3 202418 Jan 2026 - EBITDA and revenue fell YoY, but cash flow and strategic initiatives advanced.ALPEKA
Q1 202527 Dec 2025 - 2024 EBITDA beat guidance, cost savings hit $75M, and leverage improved to 2.9x.ALPEKA
Q4 202416 Dec 2025 - EBITDA and cash flow rose sequentially, but oversupply and lower prices pressured guidance.ALPEKA
Q3 202523 Oct 2025